Distinct nuclear body components, PML and SMRT, regulate the trans-acting function of HTLV-1 tax oncoprotein Journal Article


Authors: Ariumi, Y.; Ego, T.; Kaida, A.; Matsumoto, M.; Pandolfi, P. P.; Shimotohno, K.
Article Title: Distinct nuclear body components, PML and SMRT, regulate the trans-acting function of HTLV-1 tax oncoprotein
Abstract: Several viruses target cellular promyelocytic leukemia (PML)-nuclear bodies (PML-NBs) to induce their disruption, marked morphological changes in these structures or the relocation to PML-NB components to the cytoplasm of infected cells. PML conversely interferes with viral replication. We demonstrate that PML acts as a coactivator for the human T-cell leukemia virus type I (HTLV-1) Tax oncoprotein without direct binding. Tax was identified within interchromatin granule clusters (IGCs)/RNA splicing bodies (SBs), not PML-NBs; Tax expression did not affect PML-NB formation. Moreover, PML and CBP/p300 cooperatively activated Tax-mediated HTLV-1-LTR-dependent gene expression. Interestingly, two PML mutants, PML-RAR and PMLDelta216-331, which fail to form PML-NBs, could also coactivate Tax-mediated trans-acting function but had no effect on retinoic acid receptor (RAR)- or p53-dependent gene expression. In contrast, SMRT (silencing mediator for retinoic acid and thyroid hormone receptors), a nuclear corepressor found within the matrix-associated deacetylase (MAD) nuclear body, relocatized into Tax-associated nuclear bodies upon coexpression with Tax. SMRT coactivated the trans-acting function of Tax through direct binding. Coexpression of SMRT and PML resulted in an additive activation of Tax trans-acting function. Thus, crosstalk between distinct nuclear bodies may control Tax function.
Keywords: tumor suppression; acute promyelocytic leukemia; pml; bodies; cbp; rar-alpha; nuclear body; htlv-1; tax; smrt; cell leukemia-virus; creb binding-protein; replication compartments; viral transactivator; coactivator cbp; type-1 tax
Journal Title: Oncogene
Volume: 22
Issue: 11
ISSN: 0950-9232
Publisher: Nature Publishing Group  
Date Published: 2003-03-20
Start Page: 1611
End Page: 1619
Language: English
ACCESSION: WOS:000181580500003
DOI: 10.1038/sj.onc.1206244
PROVIDER: wos
PUBMED: 12642864
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors